Literature DB >> 14299436

EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II.

F KAZMIER, J A SPITTELL, J J THOMPSON, C A OWEN.   

Abstract

Keywords:  BISHYDROXYCOUMARIN; COUMARINS; DRUG THERAPY; FACTOR IX; FACTOR VII; FACTOR X; PHARMACOLOGY; PHENINDIONE; PROTHROMBIN TIME; WARFARIN

Mesh：

Substances：

Year:  1965        PMID： 14299436     DOI： 10.1001/archinte.1960.03860180039007

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  6 in total

1.  Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.

Authors:  E Chan; L Aarons; M Serlin; A Breckenridge; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

2.  Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques.

Authors:  A Girolami; A Brunetti; G Bareggi
Journal:  Blut       Date:  1972-08

Review 3.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Recurrence of thromboembolic disease after discontinuing anticoagulant therapy. A study of factors affecting incidence.

Authors:  L Michaels
Journal:  Br Heart J       Date:  1970-05

5.  Factor II, VII, IX and X concentrations in patients receiving long term warfarin.

Authors:  B Paul; A Oxley; K Brigham; T Cox; P J Hamilton
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

Review 6.  Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates.

Authors:  Lisa M Baumann Kreuziger; Joseph C Keenan; Colleen T Morton; David J Dries
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.